Literature DB >> 6732788

Presence of platelet-activating factor in blood from humans and experimental animals. Its absence in anephric individuals.

C Caramelo, S Fernández-Gallardo, D Marín-Cao, P Iñarrea, J C Santos, J M López-Novoa, M Sanchez Crespo.   

Abstract

Blood from humans and experimental animals was examined for the presence of platelet-activating factor. The procedure included a rapid extraction of the samples and a purification of the lipid content by thin layer chromatography. The chemical characterization was performed by phospholipases' treatment and high performance liquid chromatography. Rats contained the highest concentrations of platelet-activating factor and rabbits the lowest. Five anephric patients undergoing support hemodialysis had undetectable blood levels and the same finding was observed in six rats in which surgical nephrectomy was performed. Based on these data we suggest: 1) Low amounts of platelet-activating factor can be present in blood under normal conditions. 2) Kidney tissue seems to play a role in the formation of the platelet-activating factor that can be detected in blood under these conditions.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6732788     DOI: 10.1016/s0006-291x(84)80176-x

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  The role of platelet-activating factor and peptidoleukotrienes in the vascular changes of rat passive anaphylaxis.

Authors:  S Fernández-Gallardo; M A Gijón; C García; V Furio; F T Liu; M Sánchez Crespo
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

2.  Guinea pig bone marrow cells treated with platelet-activating factor generate factor(s) which affects their DNA synthesis and microbicidal activity.

Authors:  I Kudo; T Kato; H Hayashi; R Yanoshita; K Ikizawa; H Uda; K Inoue
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

3.  PAF of biological fluids in disease: IV. Levels in blood in allergic reactions induced by drugs.

Authors:  M Lazanas; C A Demopoulos; S Tournis; S Koussissis; K Labrakis-Lazanas; X Tsarouhas
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

4.  Vasodilator and constrictor actions of platelet-activating factor in the isolated microperfused afferent arteriole of the rabbit kidney. Role of endothelium-derived relaxing factor/nitric oxide and cyclooxygenase products.

Authors:  L A Juncos; Y L Ren; S Arima; S Ito
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

5.  Biosynthesis of platelet-activating factor in glandular gastric mucosa. Evidence for the involvement of the 'de novo' pathway and modulation by fatty acids.

Authors:  S Fernandez-Gallardo; M A Gijon; M C Garcia; E Cano; M Sanchez Crespo
Journal:  Biochem J       Date:  1988-09-15       Impact factor: 3.857

6.  Nutritional prevention on hypertension, cerebral hemodynamics and thrombosis in stroke-prone spontaneously hypertensive rats.

Authors:  Takanori Noguchi; Katsumi Ikeda; Yasuto Sasaki; Yukio Yamori
Journal:  Cell Mol Neurobiol       Date:  2004-10       Impact factor: 5.046

7.  Cultured endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, bradykinin, and adenosine triphosphate.

Authors:  T M McIntyre; G A Zimmerman; K Satoh; S M Prescott
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

8.  Intravascular release of a platelet-activating factor-like lipid (PAF-LL) induced by cigarette smoking.

Authors:  T Imaizumi
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

9.  A simple and precise method for the routine determination of platelet-activating factor in blood and urine.

Authors:  C A Demopoulos; N K Andrikopoulos; S Antonopoulou
Journal:  Lipids       Date:  1994-04       Impact factor: 1.880

10.  Lipoproteins alter the catalytic behavior of the platelet-activating factor acetylhydrolase in human plasma.

Authors:  D M Stafforini; M E Carter; G A Zimmerman; T M McIntyre; S M Prescott
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.